LEXINGTON, Ky., July 7 /PRNewswire-FirstCall/ -- VirtualHealth Technologies, Inc. (OTC Bulletin Board: VHGI) the owners of Veriscrip(TM) the nation's only proven Real-Time Prescription Monitoring System announced it's support today of a proposed rule that would allow for the electronic prescribing of controlled substances.
June 27th, the Drug Enforcement Administration proposed regulations that would allow physicians to electronically prescribe controlled substances. Current rules bar e-prescriptions for controlled substances, classified as medications that have the potential for abuse or addiction. Controlled substances account for between 10% and 13% of all U.S. prescriptions. The DEA hopes to reduce prescription forgery by creating a "closed system of controls on controlled-substances dispensing." In a separate initiative the House recently approved a bill (HR 6331) that would provide an incentive to physicians to use e-prescribing that would sharply increase its adoption.
According to Jim Renfro, President of VHGI, "Both of these recent events are very exciting for Veriscrip because they are key factors in facilitating the use of e-prescribing in real-time Prescription Drug Monitoring. From the beginning our company has stressed the importance of tracking controlled substances from their inception electronically." Renfro goes on further to say, "I am confident that once these rules are put into effect, you will begin to see more local and state governments moving more aggressively to curtail the misuse and major abuse of prescription drugs in a real time manner. I think we have positioned Veriscrip to be a leader in this effort and to take full advantage of the potential new business, which will result from this rule change."
This press release contains forward-looking statements that reflect the
Company's current expectations regarding future events. While these
statements reflect the Company's best current judgment, they are subject to
risks and uncertainties. Actual results may differ significantly from
projected results due to a number of factors, including, but not limited to
assumptions, beliefs and opinions relating to the business and growth
strategy of VirtualHealth Technologies, Inc. and its wholly owned
subsidiaries Verified Prescription Safeguards, Inc., VPS Holding, LLC,
Envoii Healthcare, LLC, Medical Office Software, Inc. and implementation
thereof, based upon the Company's interpretation and analysis of financial
and market conditions, the decisions of businesses with whom the Company is
either engaged in business with or negotiating, healthcare industry trends
and management's ability to successfully finance, develop, market, sell and
implement its e-commerce and internet solutions, clinical and financial
e-transaction services and software applications to physicians, pharmacies,
governmental agencies, laboratories, insurance companies, HMOs, and payers.
These factors and other risk factors are more fully discussed in the
Company's filings with the Securities and Exchange Commission. The Company
expressly disclaims any intent or obligation to update any forward-looking
Contact: Shareholder Relations
VirtualHealth Technologies, Inc.
325 West Main Street, Suite 240
Lexington, KY 40507
|SOURCE VirtualHealth Technologies, Inc.|
Copyright©2008 PR Newswire.
All rights reserved